An observational study in Pregnancy Complications, Gestational Diabetes and Obstetric Labor Complications, sponsored by Sun Yat-sen University. Recruiting at 1 site in China. Open to participants aged 15 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Sun Yat-sen University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Pregnancy Complications with a site in China — 9 open to participants now, 10 under way, none of them phase 3. Pregnancy Complications · China.
Among the 18 studies in Pregnancy Complications with a site in China, this one is the 4th largest by planned enrollment of the 11 observational ones that give a count, is one of 3 that started in 2018, is one of 11 observational ones, and was the 5th registered.
411 studies on the registry are indexed under Pregnancy Complications; 111 are open to participants now.
Browse Pregnancy Complications studies →9 of the 18 studies in Pregnancy Complications with a site in China are open now. Recruiting first, the newest first:
DeltaHealth Hospital · Shanghai · Sites in China
Ages 16–55 · Women only
Guangzhou Women and Children's Medical Center · Sites in China
Ages 18–50 · Women only · Healthy volunteers
Fudan University · Sites in China
Ages 18–40 · Women only · Healthy volunteers
Women's Hospital School Of Medicine Zhejiang University · Sites in China
Ages 18–40 · Women only
Shengjing Hospital · Sites in China
Ages 18–50 · Women only · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 90 Pregnancy Complications studies recruiting now, 43 (48%) set no upper age limit and 44 (49%) stop at 75 or younger; 22 take children under 18; 35 take healthy volunteers.
This study: 15 Years to 49 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 1999; this study’s year is marked. 3 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10,000 is above the median of 400 across 198 observational studies indexed under Pregnancy Complications.
Median enrollment 200 across the 7 interventional studies, 5,216 across the 11 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 18 has an industry lead sponsor. The 10 most frequent:
Sun Yat-sen University is the lead sponsor of 1,695 studies on the registry; 622 are open to participants now.
Sun Yat-sen University has 2 studies filed under Pregnancy Complications — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Pregnancy Complications with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The Shenzhen Birth Cohort Study was set up to investigate the effect of early life environmental exposures on short- and long-term health consequences in Shenzhen, China.
Shenzhen Birth Cohort (Xinmiao Project) is a scientific research/public health project under the support of Shenzhen city and Nanshan district, which was jointly initiated by Nanshan Maternity and Child Healthcare Hospital of Shenzhen and school of public health, Sun Yat-sen University. The project plans to recruit 10,000 participants in early pregnancy and follow up for seven years in the first stage. Biological samples, questionnaires and data for child growth and development, disease and health will be collected. The study is aimed to provide evidence for DOHaD Hypothesis and find the prevention and control measures for some childhood diseases. The core members of the research team are composed of experts from different disciplines in the field of public health, including 4 professors and 3 associate professors. With the support of an executive sponsor, the project is undertaken by the Birth Cohort Study Center. Currently, the center has 3 staff form hospital (one doctor and two masters ) and 5-7 master candidates from Sun Yat-sen University. It is an energetic and enthusiastic team.
Pregnant women attending their first routine antenatal examinations and their partners and offspring.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This cohort study have any no treatment.
Other: No intervention
This cohort study have any no intervention.
Fetal outcomes.
Including intrauterine growth retardation, abortion, stillbirth, live birth, preterm. birth, low birth weight, macrosomia and birth defects.
Time frame: At delivery.
Maternal weight changes (kg).
Assess using electronic weighing machine.
Time frame: At pre-pregnancy period, 20 weeks of gestation, 28 weeks of gestation, the time before labor and 30 days after delivery.
Number of participant with gestational complications.
Including gestational hypertension and preeclampsia, and gestational diabetes mellitus.
Time frame: At delivery.
Number of participant with postnatal depression.
Assess using Edinburgh Postnatal Depression Scale (EPDS).
Time frame: At 30 days after delivery, 3 months, 6 months after delivery.
Physical development.
Including weight changes (kg) and height changes (cm).
Time frame: at age of 1 month, 3 months, 6months, 1 year, 3 years and 6 years.
Neurodevelopment.
Including gross motor, fine motor, language, and social function, assess using Ages and Stages Questionnaires (ASQ-3 and ASQ-SE).
Time frame: at age of 1 month, 3 months, 6months, 1 year, 3 years and 5 years.
Plan to share: Undecided
No publications or documents are linked to this record.
Started Mar 2018 (actual). Primary completion is estimated for Dec 2030, 153 months after the start.
Of 113 non-industry observational studies under Pregnancy Complications, half reached primary completion within 60 months of starting (the median), counting those still running; a quarter within 30 and three quarters within 201. This study's planned 153 months is above that.
Counting every sponsor, half of 121 studies reached it within 60 months; a quarter within 30 and three quarters within 201.
Primary completion moved once since we started tracking on Sep 25, 2026: Mar 2025 → Dec 2030, on Nov 19, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.